Azzad Asset Management Inc /Adv Novo Nordisk A S Transaction History

Azzad Asset Management Inc /Adv

$858 Billion
Q1 2024

A detailed history of Azzad Asset Management Inc /Adv transactions in Novo Nordisk A S stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 35,168 shares of NVO stock, worth $4.63 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

35,168

Previous 34,975 0.55%

Holding current value

$4.63 Million

Previous $3.62 Billion 24.81%

% of portfolio

0.53%

Previous 0.46%

53 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$102.11 - $135.92 $19,707 - $26,232	193 Added 0.55%	35,168 $4.52 Billion
Q4 2023 Apr 01, 2024	BUY	$87.78 - $105.45 $102,088 - $122,638	1,163 Added 3.44%	34,975 $3.62 Billion
Q3 2023 Apr 01, 2024	BUY	$90.94 - $199.54 $1.53 Million - $3.35 Million	16,784 Added 98.57%	33,812 $3.07 Billion
Q2 2023 Apr 01, 2024	BUY	$155.98 - $172.65 $11,542 - $12,776	74 Added 0.44%	17,028 $2.76 Billion
Q1 2023 Apr 01, 2024	SELL	$132.34 - $159.14 $257,665 - $309,845	-1,947 Reduced 10.3%	16,954 $2.7 Billion

Q4 2022 Apr 01, 2024	SELL	$102.55 - $135.33 $2.21 Million - $2.92 Million	-21,593 Reduced 53.32%	18,901 $2.56 Billion
Q3 2022 Apr 01, 2024	SELL	$95.28 - $116.93 $299,179 - $367,160	-3,140 Reduced 7.2%	40,494 $3.29 Billion
Q2 2022 Apr 01, 2024	BUY	$103.24 - $121.81 $2.33 Million - $2.75 Million	22,564 Added 107.09%	43,634 $3.86 Billion
Q1 2022 Apr 01, 2024	BUY	$93.1 - $112.54 $22,064 - $26,671	237 Added 1.14%	21,070 $2.34 Billion
Q4 2021 Apr 01, 2024	SELL	$95.88 - $117.08 $169,324 - $206,763	-1,766 Reduced 7.81%	20,833 $2.33 Billion
Q3 2021 Apr 01, 2024	SELL	$84.42 - $106.62 $444,555 - $561,460	-5,266 Reduced 18.9%	22,599 $2.17 Billion
Q2 2021 Apr 01, 2024	BUY	$67.66 - $84.76 $205,686 - $257,670	3,040 Added 12.25%	27,865 $2.33 Billion
Q1 2021 Apr 01, 2024	BUY	$67.06 - $75.82 $92,274 - $104,328	1,376 Added 5.87%	24,825 $1.67 Billion
Q4 2020 Apr 01, 2024	BUY	$63.89 - $73.8 $44,020 - $50,848	689 Added 3.03%	23,449 $1.64 Billion
Q3 2020 Apr 01, 2024	BUY	$63.69 - $70.22 $61,842 - $68,183	971 Added 4.46%	22,760 $1.58 Billion
Q2 2020 Apr 01, 2024	SELL	$58.54 - $67.94 $224,559 - $260,617	-3,836 Reduced 14.97%	21,789 $1.43 Billion
Q1 2020 Apr 01, 2024	SELL	$49.46 - $64.78 $1.05 Million - $1.38 Million	-21,289 Reduced 45.38%	25,625 $1.54 Billion
Q4 2019 Apr 01, 2024	SELL	$49.86 - $58.26 $7,877 - $9,205	-158 Reduced 0.34%	46,914 $2.88 Billion
Q3 2019 Apr 01, 2024	BUY	$47.54 - $53.43 $996,676 - $1.12 Million	20,965 Added 80.3%	47,072 $2.73 Billion
Q2 2019 Apr 01, 2024	BUY	$46.79 - $52.47 $110,798 - $124,248	2,368 Added 9.98%	26,107 $1.33 Billion
Q1 2019 Apr 01, 2024	SELL	$46.36 - $52.63 $534,901 - $607,244	-11,538 Reduced 32.71%	23,739 $1.24 Billion
Q4 2018 Apr 01, 2024	SELL	$41.54 - $47.25 $128,732 - $146,427	-3,099 Reduced 8.08%	35,277 $1.63 Billion
Q3 2018 Apr 01, 2024	SELL	$46.76 - $51.24 $173,666 - $190,305	-3,714 Reduced 8.82%	38,376 $1.81 Billion
Q2 2018 Apr 01, 2024	BUY	$44.29 - $50.42 $1.86 Million - $2.12 Million	42,090 New	42,090 $1.94 Billion
Q1 2018 Apr 03, 2024	BUY	$48.49 - $58.14 $50,575 - $60,640	1,043 Added 2.41%	44,244 $2.18 Billion
Q4 2017 Apr 03, 2024	BUY	$47.53 - $53.73 $46,199 - $52,225	972 Added 2.3%	43,201 $2.32 Billion
Q3 2017 Apr 03, 2024	SELL	$41.15 - $49.22 $141,967 - $169,809	-3,450 Reduced 7.55%	42,229 $2.03 Billion
Q2 2017 Apr 03, 2024	BUY	N/A	2,869 Added 6.7%	45,679 $1.96 Billion
Q1 2017 Apr 03, 2024	BUY	N/A	20,706 Added 93.68%	42,810 $1.47 Billion
Q4 2016 Apr 03, 2024	SELL	N/A	-293 Reduced 1.31%	22,104 $793 Million
Q3 2016 Apr 03, 2024	BUY	N/A	684 Added 3.15%	22,397 $932 Million
Q2 2016 Apr 03, 2024	BUY	N/A	3,741 Added 20.82%	21,713 $1.17 Billion
Q1 2016 Apr 03, 2024	BUY	N/A	3,442 Added 23.69%	17,972 $974 Million
Q4 2015 Apr 03, 2024	BUY	N/A	251 Added 1.76%	14,530 $844 Million
Q3 2015 Apr 03, 2024	BUY	N/A	1,101 Added 8.35%	14,279 $775 Million
Q2 2015 Apr 03, 2024	BUY	N/A	4,741 Added 56.19%	13,178 $722 Million
Q1 2015 Apr 03, 2024	BUY	N/A	473 Added 5.94%	8,437 $450 Million
Q4 2014 Apr 03, 2024	SELL	N/A	-459 Reduced 5.45%	7,964 $337 Million
Q3 2014 Apr 03, 2024	BUY	N/A	241 Added 2.95%	8,423 $401 Million
Q2 2014 Apr 03, 2024	BUY	N/A	104 Added 1.29%	8,182 $378 Million
Q1 2014 Apr 03, 2024	BUY	N/A	6,297 Added 353.57%	8,078 $369 Million
Q4 2013 Apr 03, 2024	SELL	N/A	-54 Reduced 2.94%	1,781 $329 Million
Q2 2013 Apr 03, 2024	BUY	N/A	4 Added 0.22%	1,835 $310 Million
Q1 2013 Apr 03, 2024	SELL	N/A	-33,144 Reduced 94.76%	1,831 $296 Million
Q4 2012 Apr 08, 2024	SELL	N/A	-5,362 Reduced 71.87%	2,099 $343 Million
Q3 2012 Apr 08, 2024	BUY	N/A	1,421 Added 23.53%	7,461 $1.18 Billion
Q2 2012 Apr 08, 2024	BUY	N/A	443 Added 7.91%	6,040 $878 Million
Q1 2012 Apr 08, 2024	SELL	N/A	-27 Reduced 0.48%	5,597 $776 Million
Q4 2011 Apr 08, 2024	SELL	N/A	-125 Reduced 2.17%	5,624 $648 Million
Q3 2011 Apr 08, 2024	BUY	N/A	48 Added 0.84%	5,749 $572 Million
Q2 2011 Apr 08, 2024	SELL	N/A	-203 Reduced 3.44%	5,701 $714 Million
Q1 2011 Apr 08, 2024	SELL	N/A	-185 Reduced 3.04%	5,904 $739 Million
Q4 2010 Apr 08, 2024	SELL	N/A	-28,886	6,089 $685 Million

Others Institutions Holding NVO

# of Institutions

1,883

Shares Held

310M

Call Options Held

5.36M

Put Options Held

4.95M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $297B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account

Azzad Asset Management Inc /Adv Novo Nordisk A S Transaction History